John E Wolf

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. ncbi request reprint An update of recent clinical trials examining adapalene and acne
    J E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030 3411, USA
    J Eur Acad Dermatol Venereol 15:23-9. 2001
  2. ncbi request reprint The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 79:73-80. 2007
  3. ncbi request reprint Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses
    J E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030 3411, USA
    Int J Dermatol 40:709-13. 2001
  4. ncbi request reprint Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study
    John E Wolf
    Baylor College of Medicine, Dermatology Department, Houston, TX 77030, USA
    J Am Acad Dermatol 49:S211-7. 2003
  5. ncbi request reprint Maintenance therapy for acne vulgaris: the fine balance between efficacy, cutaneous tolerability, and adherence
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030 3411, USA
    Skinmed 3:23-6. 2004
  6. ncbi request reprint Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
    John E Wolf
    Baylor College of Medicine, Houston, TX 77030 3411, USA
    Int J Dermatol 46:94-8. 2007
  7. ncbi request reprint Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 77:3-11. 2006
  8. ncbi request reprint Safety and tolerability in the MORE trial
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 78:19-25. 2006
  9. ncbi request reprint Present and future rosacea therapy
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 75:4-7; discussion 33-6. 2005
  10. ncbi request reprint The treatment of rosacea
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 73:34-6. 2004

Detail Information

Publications13

  1. ncbi request reprint An update of recent clinical trials examining adapalene and acne
    J E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030 3411, USA
    J Eur Acad Dermatol Venereol 15:23-9. 2001
    ..The various studies comparing the efficacy and tolerability of adapalene with the new formulations of tretinoin are described. A summary of the findings and their implications follows...
  2. ncbi request reprint The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 79:73-80. 2007
    ..The findings of this study expand the collected data on the efficacy and safety of metronidazole topical gel 0.75% beyond that demonstrated in controlled clinical trials and confirm the utility of this therapy in the community setting...
  3. ncbi request reprint Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses
    J E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030 3411, USA
    Int J Dermatol 40:709-13. 2001
    ..Previous studies have demonstrated that 3% diclofenac in 2.5% hyaluronan gel is effective and well tolerated in the treatment of AK. The present study was designed to further explore the therapeutic potential of this gel...
  4. ncbi request reprint Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study
    John E Wolf
    Baylor College of Medicine, Dermatology Department, Houston, TX 77030, USA
    J Am Acad Dermatol 49:S211-7. 2003
    ..01), and stinging/burning (P <.05) were higher in the clindamycin plus adapalene group than in the clindamycin plus vehicle group in patients with moderate or severe irritation; in most cases these symptoms were of mild intensity...
  5. ncbi request reprint Maintenance therapy for acne vulgaris: the fine balance between efficacy, cutaneous tolerability, and adherence
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030 3411, USA
    Skinmed 3:23-6. 2004
    ..Patients may be more motivated to use agents that are easily integrated into their lifestyles and that have potential "skin-repairing" properties...
  6. ncbi request reprint Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
    John E Wolf
    Baylor College of Medicine, Houston, TX 77030 3411, USA
    Int J Dermatol 46:94-8. 2007
  7. ncbi request reprint Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 77:3-11. 2006
    ..On average, the efficacy (including reduction in erythema) of the once-daily application of metronidazole 1% gel and twice-daily applications of azelaic acid 15% gel were similar...
  8. ncbi request reprint Safety and tolerability in the MORE trial
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 78:19-25. 2006
    ..The MORE trial confirms that adapalene gel 0.1% is safe and well tolerated and therefore likely to enhance adherence to treatment and the likelihood of optimal treatment outcomes for patients with moderate to moderately severe acne...
  9. ncbi request reprint Present and future rosacea therapy
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 75:4-7; discussion 33-6. 2005
    ..However, more research is necessary to validate the efficacy and safety of newer pharmacologic agents and light-based therapy. Because rosacea is a chronic condition, pharmacologic maintenance therapy is necessary to maintain remission...
  10. ncbi request reprint The treatment of rosacea
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 73:34-6. 2004
    ..A lively discussion centered on treatment options for the various subtypes of rosacea ensued...
  11. ncbi request reprint Potential anti-inflammatory effects of topical retinoids and retinoid analogues
    John E Wolf
    Department of Dermatology, Baylor College of Medicine Houston, Texas 77030 3411, USA
    Adv Ther 19:109-18. 2002
    ..These multiple mechanisms of action should encourage clinicians to consider these agents in the first-line management of inflammatory acne lesions...
  12. doi request reprint Understanding efficacy end-points in studies of field-directed therapy for actinic keratosis
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Dermatol 52:1063-70. 2013
    ....
  13. ncbi request reprint The role of topical metronidazole in the treatment of rosacea
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 73:19-28. 2004
    ..The efficacy and tolerability of topical metronidazole in combination with an oral antibiotic or as monotherapy to maintain remissions have been shown in multiple well-controlled trials...